期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Protective effects of pharmacological therapies in animal models of multiple sclerosis: a review of studies 2014–2019 被引量:4
1
作者 Bridget Martinez Philip V.Peplow 《Neural Regeneration Research》 SCIE CAS CSCD 2020年第7期1220-1234,共15页
Multiple sclerosis(MS)is an inflammatory demyelinating disease of the central nervous system.The disability caused by inflammatory demyelination clinically dominates the early stages of relapsing-remitting MS and is r... Multiple sclerosis(MS)is an inflammatory demyelinating disease of the central nervous system.The disability caused by inflammatory demyelination clinically dominates the early stages of relapsing-remitting MS and is reversible.Once there is considerable loss of axons,MS patients enter a secondary progressive stage.Disease-modifying drugs currently in use for MS suppress the immune system and reduce relapse rates but are not effective in the progressive stage.Various animal models of MS(mostly mouse and rat)have been established and proved useful in studying the disease process and response to therapy.The experimental autoimmune encephalomyelitis animal studies reviewed here showed that a chronic progressive disease can be induced by immunization with appropriate amounts of myelin oligodendrocyte glycoprotein together with mycobacterium tuberculosis and pertussis toxin in Freund's adjuvant.The clinical manifestations of autoimmune encephalomyelitis disease were prevented or reduced by treatment with certain pharmacological agents given prior to,at,or after peak disease,and the agents had protective effects as shown by inhibiting demyelination and damage to neurons,axons and oligodendrocytes.In the cuprizone-induced toxicity animal studies,the pharmacological agents tested were able to promote remyelination and increase the number of oligodendrocytes when administered therapeutically or prophylactically.A monoclonal IgM antibody protected axons in the spinal cord and preserved motor function in animals inoculated with Theiler's murine encephalomyelitis virus.In all these studies the pharmacological agents were administered singly.A combination therapy may be more effective,especially using agents that target neuroinflammation and neurodegeneration,as they may exert synergistic actions. 展开更多
关键词 animal models autoimmune encephalomyelitis disease cuprizone-induced toxicity multiple sclerosis NEURODEGENERATION NEUROINFLAMMATION neuroprotection pharmacological agents progressive disease theiler's murine encephalomyelitis virus
在线阅读 下载PDF
The role of picornavirus infection in epileptogenesis
2
作者 Runxuan Zhang Jie Mu +2 位作者 Jing Chi Weijia Jiang Xiaosa Chi 《Acta Epileptologica》 2021年第1期37-43,共7页
Picornaviridae are a family of small positive-strand RNA viruses,and transmitted via the respiratory or fecal-oral route.The neurotropic picornaviruses can induce acute or late recurrent seizures following central ner... Picornaviridae are a family of small positive-strand RNA viruses,and transmitted via the respiratory or fecal-oral route.The neurotropic picornaviruses can induce acute or late recurrent seizures following central nervous system infection,by infecting the peripheral nerve,crossing the blood-brain barrier and migrating in the Trojan-horse method.Theiler’s murine encephalomyelitis virus(TMEV),as a member of Picornaviridae family,can cause encephalitis,leading to chronic spontaneous seizures.TMEV-infected C57BL/6 mice have been used as an animal model for exploring the mechanism of epileptogenesis and assessing new antiepileptic drugs.Astrogliosis,neuronal death and microglial recruitment have been detected in the hippocampus following the picornaviruse-induced encephalitis.The macrophages,monocytes,neutrophils,as well as IL-6 and TNF-αreleased by them,play an important role in the epileptogenesis.In this review,we summarize the clinical characteristics of picornavirus infection,and the immunopathology involved in the TMEV-induced epilepsy. 展开更多
关键词 Picornaviridae infection theilers murine encephalomyelitis virus sEIZURE Immune response
原文传递
小鼠脑脊髓炎病毒非编码蛋白片段实时荧光定量PCR标准品的构建 被引量:2
3
作者 袁文 张钰 +2 位作者 王静 刘香梅 黄韧 《实验动物与比较医学》 CAS 2012年第1期8-13,共6页
目的构建小鼠脑脊髓炎病毒(TMEV)非编码蛋白(UTR)片段标准品,用于实时荧光定量PCR检测小鼠脑脊髓炎病毒。方法RT-PCR扩增TMEVuTR片段上80-1094nt之间长度为1014bp的片段,将目的片段连接至pMD18-T载体,转化至DH5α感受态细胞。分... 目的构建小鼠脑脊髓炎病毒(TMEV)非编码蛋白(UTR)片段标准品,用于实时荧光定量PCR检测小鼠脑脊髓炎病毒。方法RT-PCR扩增TMEVuTR片段上80-1094nt之间长度为1014bp的片段,将目的片段连接至pMD18-T载体,转化至DH5α感受态细胞。分别经PCR鉴定和序列测定验证重组质粒。分光光度计测量重组质粒的吸光值,换算成拷贝数浓度后作10倍梯度稀释制得质粒标准品。然后进行实时荧光定量PCR分析,绘制标准曲线。结果TMEVUTR片段成功克隆至pMD18-T载体中,测序结果表明重组质粒中插入的UTR序列正确,实时荧光定量PCR分析10倍梯度系列稀释的质粒标准品所得到的标准曲线良好,统计学分析显示α值与标准品浓度的对数存在良好线性关系,回归系数在0.99以上。结论成功构建了TMEVUTR片段实时荧光定量PCR标准品,为今后TMEV实时荧光定量PCR检测打下了基础。 展开更多
关键词 小鼠脑脊髓炎病毒 实时荧光定量PCR 标准品
在线阅读 下载PDF
小鼠脑脊髓炎病毒自然感染调查以及人工感染小鼠试验 被引量:1
4
作者 袁文 张钰 +6 位作者 黄碧洪 罗银珠 王静 潘金春 吴瑞可 郭鹏举 黄韧 《中国比较医学杂志》 CAS 北大核心 2017年第4期75-81,共7页
目的了解小鼠脑脊髓炎病毒(TMEV)自然感染情况,探究人工感染TMEV小鼠体内各脏器组织中病毒分布及血清抗体变化。方法采用酶联免疫吸附试验(ELISA)和荧光定量RT-PCR(qRT-PCR)检测方法对2010年~2015年广东地区采集的SPF级小鼠、开放环境... 目的了解小鼠脑脊髓炎病毒(TMEV)自然感染情况,探究人工感染TMEV小鼠体内各脏器组织中病毒分布及血清抗体变化。方法采用酶联免疫吸附试验(ELISA)和荧光定量RT-PCR(qRT-PCR)检测方法对2010年~2015年广东地区采集的SPF级小鼠、开放环境饲养的小鼠以及野生褐家鼠临床样本进行TMEV检测。36只ICR小鼠经脑内接种TMEV BeAn病毒,每天观察动物的临床症状,在接种第0、3、7、10、17、21、31、39、46天每个时间点分别对3只动物安乐死,剖检并取血清和组织脏器样本进行TMEV检测。结果 SPF级小鼠TMEV抗体阳性率为5.29%(n=2834),核酸阳性率为27.27%(n=457);开放环境饲养的小鼠的抗体和核酸阳性率分别为71.95%(n=82)和53.66%(n=82);野生褐家鼠中核酸阳性率为25.93%(n=27)。TMEV阳性小鼠中仅有两只小鼠表现有明显的临床症状。盲肠内容物、粪便和脑是qRT-PCR检测的最佳选择样本。ICR小鼠脑内接种TMEV BeAn病毒后第3 d可在脑、心脏、肝脏、肺脏和胃中检测到病毒核酸,脾脏、肾脏和盲肠中未检测到病毒核酸。肝脏、心脏、肺脏和胃中的病毒在接种后第10天已完全清除,脑中的病毒一直持续存在到第46天试验结束。小鼠感染后第7天可以检测到抗体,随后抗体水平逐渐升高,接种后17 d抗体阳性率达100%,并一直到46 d都可以维持较高的抗体水平。人工感染小鼠呈隐性感染,临床上并未表现明显症状和眼观病理变化。结论广东地区实验小鼠和野生褐家鼠均存在TMEV感染,且感染率较高。小鼠接种TMEV BeAn毒株后呈隐性感染,感染小鼠第7天可以产生抗体且持续存在。病毒在感染小鼠肝脏、心脏、肺脏和胃中短时间存在,而在脑中长期存在。qRT-PCR与ELISA两种检测方法具有较好的一致性,qRT-PCR检测方法可作为实验动物国家标准的有力补充。 展开更多
关键词 小鼠脑脊髓炎病毒(tmev) 感染 检测
在线阅读 下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部